Long-Term Open-Label Solifenacin Treatment Associated with Persistence with Therapy in Patients with Overactive Bladder Syndrome
Author:
Publisher
Elsevier BV
Subject
Urology
Reference19 articles.
1. Muscarinic receptor antagonists in the treatment of overactive bladder;Chapple;Urology,2000
2. Long-term safety, tolerability and efficacy of extended-release tolterodine in the treatment of overactive bladder;Kreder;Eur Urol,2002
3. Overactive bladder survey: evaluates the extent of symptoms in family doctor setting;Wein;Fam Urol,2000
4. The standardisation of terminology in lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society;Abrams;Urology,2003
5. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study;Milsom;BJU Int,2001
Cited by 118 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14
2. Treating overactive bladder symptoms after transurethral prostatic surgery for benign prostatic hyperplasia – Which medication to choose?;Tzu Chi Medical Journal;2023
3. Mirabegron and solifenacin are effective for the management of the increased urinary frequency induced by psychological stress in female mice;Scientific Reports;2022-07-20
4. Ocular adverse effects of bladder medication: a systematic review;Cutaneous and Ocular Toxicology;2022-04-03
5. Shifting the treatment paradigm in idiopathic overactive bladder;International Journal of Clinical Practice;2021-01-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3